1-2 of 2
Hussein Mortada
Close
Sort by
Journal Articles

TET2 Exon 2 Skipping Confers Sensitivity to AraC and Is an Independent Favorable Prognostic Factor in AML Patients Treated with Intensive Chemotherapy

Aminetou Mint Mohamed, Marie Balsat, Lea Payen-Gay, Delphine Maucort-Boulch, MD PhD, Meyling Cheok, BSPharm, PhD, Hussein Mortada, Didier Auboeuf, Mohamed El-Hamri, Catherine Koering, Isabelle Tigaud, MD, Charles Dumontet, MD PhD, Emeline Cros, AE, Pascale Flandrin-Gresta, Olivier Nibourel, Claude Preudhomme, Xavier Thomas, MD PhD, Franck E. Nicolini, MD PhD, Francoise Solly, MD, Denis Guyotat, MD, Lydia Campos, MD PhD, Franck Mortreux, Eric Wattel
Journal: Blood
Blood (2014) 124 (21): 68.
https://doi.org/10.1182/blood.V124.21.68.68
Published: 2014
Journal Articles

Skipping of ATP-Binding Cassette Transporter A3 Exon 19 in AML Cells Is an Independent Prognostic Factor in Patients with Normal Cytogenetics

Aminetou Mint Mohamed, Morgan Thenoz, Lea Payen-Gay, Delphine Maucort-Boulch, MD PhD, Hussein Mortada, Didier Auboeuf, Catherine Koering, Meyling Cheok, Olivier Nibourel, Claude Preudhomme, Mohamed El-Hamri, Xavier Thomas, MD PhD, Franck E. Nicolini, MD PhD, Isabelle Tigaud, MD, Emeline Cros, AE, Charles Dumontet, MD PhD, Lydia Campos, MD PhD, Francoise Solly, MD, Denis Guyotat, MD, Pascale Flandrin-Gresta, Franck Mortreux, Eric Wattel
Journal: Blood
Blood (2014) 124 (21): 2324.
https://doi.org/10.1182/blood.V124.21.2324.2324
Published: 2014